Immediate Impact

3 by Nobel laureates 12 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Future therapies for cystic fibrosis
2023 Standout
Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
2023 StandoutScienceNobel
1 intermediate paper

Works of Alexander Staab being referenced

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
2014
A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus
2006

Author Peers

Author Last Decade Papers Cites
Alexander Staab 531 228 434 411 54 2.0k
Žhong Yuan 374 795 583 682 98 3.0k
Rajanikanth Madabushi 276 88 430 267 57 1.8k
Vijay Upreti 472 58 388 272 55 1.7k
Tong Yin 400 333 1104 377 101 3.0k
Roland Valdes 225 356 831 809 77 2.7k
Linnea M. Baudhuin 316 134 844 329 69 2.3k
Jürgen Venitz 594 73 1093 221 87 2.8k
Charles S. Eby 229 415 267 742 60 2.9k
Michael J. Hanley 317 76 658 285 109 2.4k
Diane K. Jorkasky 138 337 341 418 68 1.7k

All Works

Loading papers...

Rankless by CCL
2026